Have a feature idea you'd love to see implemented?
Let us know!
ENZ Enzo Biochem Inc
Price (delayed)
$1.165
Market cap
$59.95M
P/E Ratio
1.27
Dividend/share
N/A
EPS
$0.92
Enterprise value
$10.05M
Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous
Highlights
The EPS has soared by 198% YoY and by 37% from the previous quarter
Enzo Biochem's net income has soared by 198% YoY and by 37% from the previous quarter
Enzo Biochem's debt has shrunk by 67% YoY but it has increased by 2.1% QoQ
Enzo Biochem's gross margin has decreased by 7% from the previous quarter
ENZ's equity is down by 2.5% from the previous quarter
Key stats
What are the main financial stats of ENZ
Market
Valuations
Earnings
Shares outstanding
51.46M
Market cap
$59.95M
Enterprise value
$10.05M
Price to earnings (P/E)
1.27
Price to book (P/B)
0.86
Price to sales (P/S)
12.64
EV/EBIT
0.23
EV/EBITDA
0.22
EV/Sales
2.13
Revenue
$4.72M
EBIT
$43.35M
EBITDA
$44.83M
Free cash flow
-$43.2M
Per share
Balance sheet
Liquidity
EPS
$0.92
Free cash flow per share
-$0.84
Book value per share
$1.35
Revenue per share
$0.09
TBVPS
$1.83
Total assets
$93.47M
Total liabilities
$24.44M
Debt
$7.26M
Equity
$69.03M
Working capital
$54.07M
Debt to equity
0.11
Current ratio
3.5
Quick ratio
2.82
Net debt/EBITDA
-1.11
Margins
Efficiency
Dividend
EBITDA margin
949.7%
Gross margin
349%
Net margin
947.5%
Operating margin
86.8%
Return on assets
42.5%
Return on equity
61.2%
Return on invested capital
269.7%
Return on capital employed
60.4%
Return on sales
918.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ENZ stock price
How has the Enzo Biochem stock price performed over time
Intraday
3.1%
1 week
2.19%
1 month
4.02%
1 year
-17.38%
YTD
-16.19%
QTD
4.02%
Financial performance
How have Enzo Biochem's revenue and profit performed over time
Revenue
$4.72M
Gross profit
$16.48M
Operating income
$4.1M
Net income
$44.73M
Gross margin
349%
Net margin
947.5%
Enzo Biochem's net income has soared by 198% YoY and by 37% from the previous quarter
The operating income has soared by 115% YoY
The company's revenue has surged by 115% YoY and by 13% QoQ
Enzo Biochem's net margin has increased by 22% QoQ
Growth
What is Enzo Biochem's growth rate over time
Valuation
What is Enzo Biochem stock price valuation
P/E
1.27
P/B
0.86
P/S
12.64
EV/EBIT
0.23
EV/EBITDA
0.22
EV/Sales
2.13
The EPS has soared by 198% YoY and by 37% from the previous quarter
ENZ's P/E is 46% below its last 4 quarters average of 2.3
The P/B is 60% less than the 5-year quarterly average of 2.1 and 6% less than the last 4 quarters average of 0.9
ENZ's equity is down by 2.5% from the previous quarter
The P/S is 175% above the 5-year quarterly average of 4.5
The company's revenue has surged by 115% YoY and by 13% QoQ
Efficiency
How efficient is Enzo Biochem business performance
ENZ's ROA has soared by 172% year-on-year and by 30% since the previous quarter
ENZ's ROE has soared by 151% YoY and by 14% QoQ
The ROIC has soared by 78% from the previous quarter
The ROS has grown by 20% from the previous quarter
Dividends
What is ENZ's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ENZ.
Financial health
How did Enzo Biochem financials performed over time
The total liabilities has plunged by 54% YoY and by 14% from the previous quarter
ENZ's total assets is up by 30% year-on-year but it is down by 6% since the previous quarter
Enzo Biochem's debt is 89% lower than its equity
The debt to equity has plunged by 91% YoY but it has grown by 10% from the previous quarter
Enzo Biochem's debt has shrunk by 67% YoY but it has increased by 2.1% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.